ClinicalTrials.gov
public full text
Public Domain
Immune Modulation Therapy for Pompe Disease
The purpose of this study is to assess anti-recombinant human acid α-glucosidase (anti-rhGAA) antibody titers after treatment with immune modulation therapy in patients of Pompe disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease#802819
- Evaluation of the Safety and Efficacy of Infantile-onset Pompe Disease Gene Therapy Drug#869220
- Drug-drug Interaction Study#1112984
- Effect of Belimumab on Antibody Titers in Primary APS Patients#1211694
- Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease#828450
Record · ID 1364022
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive